{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T16:54:55Z","timestamp":1722963295309},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5-6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.2119\/molmed.2011.00039","type":"journal-article","created":{"date-parts":[[2011,5,26]],"date-time":"2011-05-26T14:11:39Z","timestamp":1306419099000},"page":"363-368","source":"Crossref","is-referenced-by-count":19,"title":["Effects of the Histone Deacetylase Inhibitor ITF2357 in Autoinflammatory Syndromes"],"prefix":"10.1186","volume":"17","author":[{"given":"Evelien J","family":"Bodar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos W M","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,25]]},"reference":[{"key":"1705363_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","volume":"97","author":"MF McDermott","year":"1999","unstructured":"McDermott MF, et al. (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 97:133\u20134.","journal-title":"Cell"},{"key":"1705363_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","volume":"27","author":"SL Masters","year":"2009","unstructured":"Masters SL, Simon A, Aksentijevich I, Kastner DL. (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu. Rev. Immunol. 27:621\u201368.","journal-title":"Annu. Rev. Immunol."},{"key":"1705363_CR3","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/ard.2005.045245","volume":"65","author":"HD Koning de","year":"2006","unstructured":"de Koning HD, et al. (2006) Beneficial response to anakinra and thalidomide in Schnitzler\u2019s syndrome. Ann. Rheum. Dis. 65:542\u20134.","journal-title":"Ann. Rheum. Dis."},{"key":"1705363_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.semarthrit.2007.04.001","volume":"37","author":"HD Koning de","year":"2007","unstructured":"de Koning HD, Bodar EJ, van der Meer JW, Simon A. (2007) Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin. Arthritis. Rheum. 37:137\u201348.","journal-title":"Semin. Arthritis. Rheum."},{"key":"1705363_CR5","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1182\/blood.V85.12.3586.bloodjournal85123586","volume":"85","author":"JPH Drenth","year":"1995","unstructured":"Drenth JPH, van Deuren M, van der Ven-Jongekrijg J, Schalkwijk CG, van der Meer JWM. (1995) Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood. 85:3586\u201393.","journal-title":"Blood"},{"key":"1705363_CR6","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1002\/art.10550","volume":"46","author":"J Frenkel","year":"2002","unstructured":"Frenkel J, et al. (2002) Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum. 46:2794\u2013803.","journal-title":"Arthritis Rheum."},{"key":"1705363_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/rheumatology\/kei090","volume":"45","author":"ML Nowlan","year":"2006","unstructured":"Nowlan ML, et al. (2006) Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A. Rheumatology (Oxford). 45:31\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"1705363_CR8","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1002\/art.21964","volume":"54","author":"SL Rebelo","year":"2006","unstructured":"Rebelo SL, et al. (2006) Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function. Arthritis Rheum. 54:2674\u201387.","journal-title":"Arthritis Rheum."},{"key":"1705363_CR9","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1002\/art.10688","volume":"46","author":"I Aksentijevich","year":"2002","unstructured":"Aksentijevich I, et al. (2002) De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatalonset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 46:3340\u20138.","journal-title":"Arthritis Rheum."},{"key":"1705363_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1097-2765(03)00056-X","volume":"11","author":"JJ Chae","year":"2003","unstructured":"Chae JJ, et al. (2003) Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol. Cell. 11:591\u2013604.","journal-title":"Mol. Cell"},{"key":"1705363_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s00296-004-0471-z","volume":"25","author":"A Cefle","year":"2005","unstructured":"Cefle A, et al. (2005) A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis. Rheumatol. Int. 25:442\u20136.","journal-title":"Rheumatol. Int."},{"key":"1705363_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","volume":"81","author":"KM Hull","year":"2002","unstructured":"Hull KM, et al. (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore). 81:349\u201368.","journal-title":"Medicine (Baltimore)"},{"key":"1705363_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10238-005-0071-6","volume":"5","author":"JC Hilst van der","year":"2005","unstructured":"van der Hilst JC, Simon A, Drenth JP. (2005) Hereditary periodic fever and reactive amyloidosis. Clin. Exp. Med. 5:87\u201398.","journal-title":"Clin. Exp. Med."},{"key":"1705363_CR14","first-page":"260","volume":"63","author":"EJ Bodar","year":"2005","unstructured":"Bodar EJ, van der Hilst JC, Drenth JP, van der Meer JW, Simon A. (2005) Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth. J. Med. 63:260\u20134.","journal-title":"Neth. J. Med."},{"key":"1705363_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.amjmed.2004.02.039","volume":"117","author":"A Simon","year":"2004","unstructured":"Simon A, et al. (2004) Beneficial response to interleukin 1 receptor antagonist in traps. Am. J. Med. 117:208\u201310.","journal-title":"Am. J. Med."},{"key":"1705363_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2119\/2006-00005.Dinarello","volume":"11","author":"F Leoni","year":"2005","unstructured":"Leoni F, et al. (2005) The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo. Mol. Med. 11:1\u201315.","journal-title":"Mol. Med."},{"key":"1705363_CR17","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1182\/blood-2006-03-014126","volume":"108","author":"S Carta","year":"2006","unstructured":"Carta S, et al. (2006) Histone deacetylase inhibitors prevent exocytosis of interleukin-1beta-containing secretory lysosomes: role of micro-tubules. Blood. 108:1618\u201326.","journal-title":"Blood"},{"key":"1705363_CR18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.clpt.2004.01.012","volume":"75","author":"A Simon","year":"2004","unstructured":"Simon A, et al. (2004) Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin. Pharmacol. Ther. 75:476\u201383.","journal-title":"Clin. Pharmacol. Ther."},{"key":"1705363_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2119\/molmed.2011.00020","volume":"17","author":"A Furlan","year":"2011","unstructured":"Furlan A, et al. (2011) Pharmacokinetics, safety and inducible cytokine responses during a phase 1 trial of the oral histone deacetylase inhibitor ITF2357 (givinostat). Mol. Med. 17:353\u2013362.","journal-title":"Mol. Med."},{"key":"1705363_CR20","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0140-6736(04)17401-1","volume":"364","author":"HM Hoffman","year":"2004","unstructured":"Hoffman HM, et al. (2004) Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet. 364:1779\u201385.","journal-title":"Lancet"},{"key":"1705363_CR21","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/art.30238","volume":"63","author":"J Vojinovic","year":"2011","unstructured":"Vojinovic J, et al. (2011) Safety and efficacy of an oral histone deacetylase inhibitor in systemiconset juvenile idiopathic arthritis. Arthritis Rheum. 63:1452\u20138.","journal-title":"Arthritis Rheum."},{"key":"1705363_CR22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2119\/molmed.2011.00030","volume":"17","author":"J Vojinovic","year":"2011","unstructured":"Vojinovic J, Damjanov N. (2011) HDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritis. Mol. Med. 17:397\u2013403.","journal-title":"Mol. Med."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.crossref.org\/molmed.2011.00039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2011.00039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T17:11:18Z","timestamp":1592586678000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2011.00039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,25]]},"references-count":22,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["1705363"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2011.00039","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,25]]}}}